PLA2G4A and pulmonary arterial hypertension: Further, the pro-inflammatory bioactive lipid pathway (Cox2) was elevated in response to the MCA/LMW PAH mixture/B[a]P treatment group at the mRNA expression level for Cox2 (Figure 6A), with a trend for increased cPla2 gene expression.